Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence-Reference-Cited by-同舟云学术

Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence

Published:2017-11-27 Issue:1 Volume:50 Page:62-72
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Turcan Sevin,Makarov Vladimir,Taranda Julian,Wang Yuxiang,Fabius Armida W. M.^ORCID,Wu Wei,Zheng Yupeng,El-Amine Nour,Haddock Sara,Nanjangud Gouri^ORCID,LeKaye H. Carl,Brennan Cameron,Cross Justin,Huse Jason T.,Kelleher Neil L.^ORCID,Osten Pavel,Thompson Craig B.,Chan Timothy A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/s41588-017-0001-z.pdf

Reference61 articles.

1. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008).

2. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009).

3. Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009).

4. Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012).

5. Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012).

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valproic acid targets IDH1 mutants through alteration of lipid metabolism;npj Metabolic Health and Disease;2024-08-13

2. IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming in a metabolic enzyme independent manner;2024-08-05

3. IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming in a metabolic enzyme independent manner;2024-08-05

4. Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects;Frontiers in Cell and Developmental Biology;2024-08-02

5. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives;Cancers;2024-08-02